Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Max Planck researchers channel microcapsules into tumour cells and release their contents using a laser impulse
Slashdot It! Slashdot Max Planck researchers channel microcapsules into tumour cells and release their contents using a laser impulse
Submit to Reddit Submit Max Planck researchers channel microcapsules into tumour cells and release their contents using a laser impulse to Reddit
Reading: Max Planck researchers channel microcapsules into tumour cells and release their contents using a laser impulseTwitter This Reading: Max Planck researchers channel microcapsules into tumour cells and release their contents using a laser impulseTwitter Max Planck researchers channel microcapsules into tumour cells and release their contents using a laser impulse
Add to Facebook Add Max Planck researchers channel microcapsules into tumour cells and release their contents using a laser impulse to Facebook

Max Planck researchers channel microcapsules into tumour cells and release their contents using a laser impulse

August 24, 2006

Treating malignant tumours is difficult. Doctors have to destroy the tumour, but healthy tissue needs to be preserved. Chemotherapy tends to kill diseased cells, at the same time causing great damage to the body in general. So scientists are looking for ways to destroy only the rampant tumour cells. One way to achieve this is to transport substances inside of microcapsules into the tumour cells and release them there. Researchers led by André Skirtach and Gleb Sukhorukov at the Max Planck Institute of Colloids and Interfaces in Potsdam, Germany, along with Wolfgang Parak at Ludwig-Maximilian-University in Munich, have now used a laser as a means of opening microcapsules inserted into a tumour cell. The capsules subsequently release their contents, a fluorescent test substance, into the cell. The scientists used a light microscope to monitor how the luminous materials distribute themselves within the cell.

The vehicle that the researchers used was a polymer capsule only a few micrometres in diameter. The walls of the capsules were built from a number of layers of charged polymers, alternating positive and negative. In the laboratory, at least, this is an established way of producing transport containers for medicines, cosmetics, or nutrients, which can also pass through cell membranes. André Skirtach and his colleagues equipped the capsules with a kind of "open sesame". But it didn't require any magic-just nanoparticles made of gold or silver atoms. The scientists mixed together charged metal nanoparticles along with the polymers composing the walls of the vesicle. The tumour cells absorbed the microcapsules and then the scientists aimed an infrared laser at them. Metal nanoparticles are particularly good at absorbing the laser light and transmitting the heat further into their surroundings, heating up the walls. They became so hot that the bonds broke between the polymers and the shell and the capsules eventually opened.




For the time being, the scientists have only been trying out their methods on isolated tumour cells. "In principle, however, active substances could be released into the body this way," says Helmuth Möhwald, director of the Max Planck Institute of Colloids and Interfaces, and one of the participating scientists. This has to (do) with the fact that infrared laser light can penetrate at least one centimetre deep into the tissue. The cells of the body heat up negligibly because laser light at this wavelength is insignificantly absorbed in the tissue. It is the metal particles in the walls of the microcapsules only that absorb the light-even when the microcapsules are in a cell, because the laser affects only them.

Besides using a "thermal opener", the scientists have found another way of making the capsules more stable. They simply heat up the newly created microcapsules very slightly, so that the diameter of the hollow capsules becomes smaller. At the same time, the molecules in their shell are located closer to each other, thickening the capsule walls and better protecting their contents.

There is still, however, a major problem to solve before scientists can use this technology to create medicines which squeeze microcapsules into tumour cells. There is still no way to "steer" the microcapsules. Helmuth Möhwald says, "we have to add some kind of feature to the capsules so that they only recognise the target cells." Only these cells would then allow microcapsules through their membrane.

Max Planck Society for the Advancement of Science





Science News and Science Current Events Tag Cloud
This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size.
Circadian Rhythms   Genome   Ear Infection   Medical Imaging   Erectile dysfunction   Biomarkers   Nicotine Dependence   Acute Lymphoblastic Leukemia   Brain Development   Serotonin   Genome Sequencing   Curcumin   DNA damage   Bivalirudin   Clostridium difficile   Mortality Rate   Behavior   Invisibility Cloak   Breastfeeding   Large Hadron Collider   Cardiac Death   Glaucoma   Fuel Cell   Spinal Cord Injury   Lymphedema  
Related Tumour Current Events and Tumour News Articles Tumour Current Events and Tumour News RSS Tumour Current Events and Tumour News RSS
New clue into how brain stem cells develop into cells which repair damaged tissue
The joint research, funded by the National Multiple Sclerosis Society and the UK MS Society as well as the National Institutes of Health and Howard Hughes Medical Institute, was conducted by scientists at the University of California San Francisco (UCSF) and University of Cambridge and was published today (01 July) in the journal Genes and Development.

Prostate Cancer Translational Research in Europe meeting: Search for biomarkers continues
Collaboration in prostate cancer translational research in Europe is not only vital to sustain the progress achieved in recent years but also to streamline current efforts between researchers and clinicians and avoid duplication or overlaps.

Discovery of the cell's water gate may lead to new cancer drugs
The flow of water into and out from the cell may play a crucial role in several types of cancer. Scientists at the University of Gothenburg have now found the gate that regulates the flow of water into yeast cells.

3 studies confirm the value of etanercept therapy in treating juvenile idiopathic arthritis
Three new studies have individually shown the anti-TNF (tumour necrosis factor) therapy etanercept to be effective, with a good safety profile, in children under four years of age with juvenile idiopathic arthritis (JIA).

Hormone therapy may confer more aggressive properties to prostate tumours
Hormone therapy is often given to patients with advanced prostate cancer.

Genetic pathway responsible for link between body clock disturbance and worsening arthritis
The genes that regulate human circadian rhythm, or 'the body clock', are significantly disturbed in individuals with arthritis.

An innovative surgical technique gives hope to patients suffering from refractory epilepsy
Clinicians from the Centre hospitalier de l'Université de Montréal (CHUM) have perfected an operation, which was previously considered too dangerous, to control refractory insular epilepsy, using an innovative microsurgery technique.

Breakthrough in radiotherapy promises targeted cancer treatment
Current radiation therapy treatment damages a patient's healthy tissue as well as eradicating the tumour it is intended to destroy, making the treatment especially invasive and often causing nasty side effects.

Key protein regulating inflammation may prove relevant to controlling sepsis
Scientists at Singapore's Institute of Molecular and Cell Biology (IMCB), under the Agency for Science, Technology and Research (A*STAR), have identified the protein, WIP1, as the molecular "brake" that curbs severe inflammation in the body.

Brain research shows past experience is invaluable for complex decision making
Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have shown that past experience really does help when we have to make complex decisions based on uncertain or confusing information.
More Tumour Current Events and Tumour News Articles
WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue
by Steven H. Swerdlow (Editor), Elias Campo (Editor), Nancy Lee Harris (Editor), Elaine S. Jaffe (Editor), Stefano A. Pileri (Editor)

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue is the third volume in the new WHO series on histological and genetic typing of human tumors. This authoritative, concise reference book covers the entire range of leukaemias and lymphomas. It provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome. Diagnostic criteria, pathological features, and associated genetic alterations are described in a strictly disease-oriented manner. Sections on all recognized neoplasms and their variants include new ICD-O codes, incidence, age and sex distribution, location, clinical signs and symptoms, pathology, genetics, and predictive factors.

Tumour Necrosis Factor

Tumour Necrosis Factor
by Zero Substance Records



Histological Typing of Soft Tissue Tumours

Histological Typing of Soft Tissue Tumours
by Springer

The publication in the series are not intended to serve as textbooks, but rather to promote the adoption of a uniform terminology that will facilitate communication amoung cancer workers. For this reason, the literature references have intentionally been omitted and readers should refer to standard works for bibliographics.

Tumour Necrosis Factor

Tumour Necrosis Factor
by Tumour of Soul

Tumour of Soul formed in June 2000 in Tomaszów Mazowiecki. The band play characterizes their music thrash/death metal which is characterized by fast melodic riffs and powerfully tempo changes; causing undeniable desires to head bang. Tumour of Soul has won three live competitions (Tomaszów Mazowiecki 2003,Warszawa Dorozkarnia 2005, Lublin 2006) and also frequently supports prominent Polish bands (Acid Drinkers, Closterkeller, Zalef, Normalsi). The band behaves as it should behave. Atomic head banging, vocalist s charisma and effective drummer s playing cause that the audience to go mad from the very beginning. After nine years of warming up; Tumor of Soul releases "Tumour Necrosis Factor" on Zero Substance Records. Ten hard-hitting, headbanging songs filled with menacing vocals,...

Horse 1816 Tumour Elbow Knee Leg Medical Old Print

Horse 1816 Tumour Elbow Knee Leg Medical Old Print
by old-print

Old Antique Historical Victorian Prints Maps and Historic Fine Art ----------. Horse 1816 Tumour Elbow Knee Leg Medical Old Print Print From The Complete Farrier & British Sportsman 1816Date Will Be In The Title If It Is Knowngenuine Clearance Now Up To 90% Off Retailfrom A Quality Lot. That Was Purchased From An Old Antique Print Dealer At An Auctionsize Varies From Scan Size Of Aprox 14.5 X 10.25 Inches ( 360 X 260 )All Are Genuine Antique And Not Modern Copies

Bluffmaster

Bluffmaster
Starring: Abhishek Bachchan, Priyanka Chopra, Nana Patekar, Boman Irani
Directed By: Rohan Sippy
Also With: Ramesh Sippy (Producer)



Obscene Extreme 2005

Obscene Extreme 2005

DVD 1 PATOLOGICUM - 2 songs MALKAVIAN - 3 songs C.M.P. - 4 songs CAEDERE - 1 song BOMBSTRIKE - 4 songs THIRD DEGREE - 2 songs DISKONTO - 3 songs KRONOS - 2 songs AMOEBIC DYSENTERY - 5 songs INGROWING - 3 songs LENG TCH´E - 4 songs DISFEAR - 6 songs BLOOD DUSTER - 6 songs PUNGENT STENCH - 4 songs INFERIA - 3 songs PURGATORY - 2 songs NEEDFUL THINGS - 5 songs ONANIZER - 2 songs DVD 2 PROFESOR LEFEBVRE - 2 songs GUIDED CRADLE - 2 songs M.A.C. OF MAD - 2 songs EXHALE - 2 songs MASS GENOCIDE PROCESS - 2 songs C.O.S. - 4 songs DEFLORACE - 1 song PLASTIC GRAVE - 2 songs FORGARDUR HELVITIS - 4 songs DEATH REALITY - 1 song HOLOCAUSTO CANIBAL - 2 songs COLLISION - 5 songs MINDSNARE - 1 song SCREAMIN´ DAEMON - 2 songs STOMA - 3 songs AUDIO KOLLAPS - 2...

  WHO Classification of Tumours of the Central Nervous System
by D.N. Louis (Author), H. Ohgaki (Author), O.D. Wiestler (Author), W.K. Cavenee (Author)

WHO Classification of Tumours of the Central Nervous System is the first volume of the 4th Edition of the World Health Organization series on histological and genetic typing of human tumors. This authoritative, concise reference book provides an international standard for oncologists and pathologists and will serve as an indispensable guide for use in the design of studies monitoring response to therapy and clinical outcome.

Diagnostic criteria pathological features and associated genetic alterations are described in a strictly disease-oriented manner. Sections on all recognized neoplasms and their variants include new ICD-O codes, incidence age and sex distribution, location, clinical signs and symptoms, pathology, genetics, and predictive factors.

This...

Revivin

Revivin
by Chi Enterprise

Revivin is designed to benefit cancer and symptoms of poor immunity. Clinical studies in human tumor cells compared Revivin to the most popular chemotherapy agents, showing the following results for colon, breast, and liver cancer: Revivin is more sensitive than Vincristin and Mytomycin. For colon and liver, Revivin is more sensitive than 5-Fu. For breast and cervical, Revivin is more sensitive that Cis-Platin. Revivin is non-toxic and, unlike chemotherapy, has NO side effects. It also helps reduce pain and inflammation, helps stop bleeding, and is good for stomach functions.

WHO Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs

WHO Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs
by G. Sauter (Author), International Agency for Research on Cancer (Author), J. N. Eble (Editor), J. I. Epstein (Editor)

This new volume in the WHO series on histological and genetic typing of human tumours covers tumours of the kidney, the urinary system, the prostate, the testis and paratesticular tissue and the penis. Each entity is extensively discussed with information on clinicopathological, epidemiological, immunophenotypic and genetic aspects of these diseases. This book is an authoritative, concise reference, prepared by 131 authors from 22 countries. It contains more than 800 colour photographs, numerous MRIs, ultrasound images, CT scans, charts and 3000 references.

© 2009 BrightSurf.com